Published in Gastroenterology on May 01, 1979
Erythromycin accelerates gastric emptying after pancreaticoduodenectomy. A prospective, randomized, placebo-controlled trial. Ann Surg (1993) 3.17
Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut (1987) 1.68
Gastrointestinal hormones in short bowel syndrome. Peptide YY may be the 'colonic brake' to gastric emptying. Gut (1996) 1.60
Chemical heterogeneity in cerebellar Purkinje cells: existence and coexistence of glutamic acid decarboxylase-like and motilin-like immunoreactivities. Proc Natl Acad Sci U S A (1981) 1.50
Decreased plasma motilin concentrations in pregnancy. Br Med J (Clin Res Ed) (1982) 1.12
Gut hormones in tropical malabsorption. Br Med J (1979) 1.05
Somatostatin, gastrointestinal peptides, and the carcinoid syndrome. Gut (1981) 0.96
Gut-hormone profile in totally pancreatectomised patients. Gut (1981) 0.81
A survey of endocrine cells in the pancreas of the echidna (Tachyglossus aculeatus) with special reference to pancreatic motilin cells. J Anat (1990) 0.79
Exogenous motilin affects postprandial proximal gastric motor function and visceral sensation. Dig Dis Sci (2002) 0.78
Importance of the jejunal hormone motilin. J Clin Pathol Suppl (Assoc Clin Pathol) (1978) 0.76
Gut hormone responses after reconstructive surgery for ulcerative colitis. Gut (1989) 0.76
Effect of EM574 on postprandial pancreaticobiliary secretion, gastric motor activity, and emptying in conscious dogs. Dig Dis Sci (1999) 0.75
The diagnosis and management of adult intussusception. Am J Surg (1997) 9.29
Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature (1998) 7.36
Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab (2001) 6.41
A role for glucagon-like peptide-1 in the central regulation of feeding. Nature (1996) 6.03
Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet (1987) 4.97
The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology (2000) 3.80
Ghrelin causes hyperphagia and obesity in rats. Diabetes (2001) 3.62
A glucagonoma syndrome. Lancet (1974) 3.56
Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology (1985) 3.36
Vasoactive intestinal peptide and watery-diarrhoea syndrome. Lancet (1973) 3.22
Possible dual role for vasoactive intestinal peptide as gastrointestinal hormone and neurotransmitter substance. Lancet (1976) 3.08
Distribution and release of human pancreatic polypeptide. Gut (1976) 3.02
Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology (2005) 2.80
Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function. Gut (1971) 2.75
Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. Lancet (1974) 2.65
Neuron-specific enolase is produced by neuroendocrine tumours. Lancet (1981) 2.63
Breast vs bottle: endocrine responses are different with formula feeding. Lancet (1980) 2.52
Measurement of fasting and postprandial plasma VIP in man. Gut (1978) 2.48
Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J Clin Invest (1999) 2.48
Nesidioblastosis of the pancreas: definition of the syndrome and the management of the severe neonatal hyperinsulinaemic hypoglycaemia. Arch Dis Child (1981) 2.36
Central and peripheral administration of kisspeptin-10 stimulates the hypothalamic-pituitary-gonadal axis. J Neuroendocrinol (2004) 2.27
Gut-hormone profile in coeliac disease. Lancet (1978) 2.25
Saturation of fat and cholecystokinin release: implications for pancreatic carcinogenesis. Lancet (1989) 2.25
Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers. Am J Physiol Endocrinol Metab (2001) 2.24
Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J Immunol (2001) 2.20
Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue. Biochem Biophys Res Commun (1979) 2.16
Gut hormones and appetite control. Gastroenterology (2007) 2.16
A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. Endocrinology (1998) 2.14
Pancreatic polypeptide in insulinomas, gastrinomas, vipomas, and glucagonomas. Lancet (1976) 2.13
The ileal brake--inhibition of jejunal motility after ileal fat perfusion in man. Gut (1984) 2.11
Neuropeptide Y distribution in the rat brain. Science (1983) 2.10
Growth-hormone release-inhibiting hormone in gastrointestinal and pancreatic D cells. Lancet (1975) 2.04
The role of the sympathetic innervation in the control of plasma glucagon concentration in the calf. J Physiol (1973) 2.01
Advanced carcinoma of the prostate: treatment with a gonadotrophin releasing hormone agonist. Br Med J (Clin Res Ed) (1983) 1.93
Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety. Br J Surg (2006) 1.91
Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39. Diabetes (1999) 1.90
Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. J Clin Invest (1997) 1.89
Calcitonin gene-related peptide immunoreactivity in the spinal cord of man and of eight other species. J Neurosci (1984) 1.88
Intracellular activation of digestive zymogens in rat pancreatic acini. Stimulation by high doses of cholecystokinin. J Clin Invest (1991) 1.87
Effects of stimulation of the chorda tympani in bursts on submaxillary responses in the cat. J Physiol (1982) 1.84
Suppression of pancreatic endocrine tumour secretion by long-acting somatostatin analogue. Lancet (1979) 1.81
Development of neuroendocrine tumors in the gastrointestinal tract of transgenic mice. Heterogeneity of hormone expression. Am J Pathol (1990) 1.80
Possible role of transforming growth factor alpha in the pathogenesis of Ménétrier's disease: supportive evidence form humans and transgenic mice. Gastroenterology (1992) 1.77
Increased leptin levels in serum and peritoneal fluid of patients with pelvic endometriosis. J Clin Endocrinol Metab (2000) 1.75
Enkephalin-like immunoreactivity in the human gastrointestinal tract. Lancet (1977) 1.75
Unusual permeability properties of gastric gland cells. Nature (1994) 1.74
Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight. Endocrinology (1997) 1.74
The effect of truncal and selective vagotomy on the release of pancreatic glucagon, insulin and enteroglucagon. Br J Surg (1974) 1.73
Bombesin-like immunoreactivity in the lung. Nature (1978) 1.73
Localization of insulinomas by selective intraarterial calcium injection. J Clin Endocrinol Metab (1996) 1.72
Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. Lancet (1974) 1.71
Pancreatic polypeptide reduces appetite and food intake in humans. J Clin Endocrinol Metab (2003) 1.71
Abnormalities of vasoactive intestinal polypeptide-containing nerves in Crohn's disease. Gastroenterology (1980) 1.70
Bromocriptine treatment of acromegaly. Br Med J (1975) 1.70
An enteroglucagon tumour. Gut (1972) 1.69
Mechanism of pancreatic polypeptide release in man. Lancet (1977) 1.68
Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut (1987) 1.68
Motilin and the interdigestive migrating motor complex in man. Dig Dis Sci (1979) 1.67
Neuropeptide Y distribution in human brain. Nature (1984) 1.66
A radioimmunoassay for neurotensin in human plasma. J Endocrinol (1979) 1.66
Glucagon-like peptide-1 is a physiological incretin in rat. J Clin Invest (1995) 1.66
Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat. Endocrinology (1999) 1.65
Bombesin: action on gut hormones and calcium in man. J Clin Endocrinol Metab (1982) 1.65
Food fails to suppress ghrelin levels in obese humans. J Clin Endocrinol Metab (2002) 1.65
Changing trends in the management of phaeochromocytoma. Br J Surg (1998) 1.62
Vasoactive intestinal peptide in relation to atropine resistant vasodilatation in the submaxillary gland of the cat. J Physiol (1980) 1.62
Treatment of carcinoid liver metastases by hepatic-artery embolisation. Lancet (1978) 1.62
Ghrelin increases food intake in obese as well as lean subjects. Int J Obes (Lond) (2005) 1.62
Gastrointestinal hormones in short bowel syndrome. Peptide YY may be the 'colonic brake' to gastric emptying. Gut (1996) 1.60
A retrospective analysis of 1570 appendiceal carcinoids. Am J Gastroenterol (1998) 1.59
Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion. Am J Gastroenterol (1995) 1.59
Helicobacter pylori alters gastric epithelial cell cycle events and gastrin secretion in Mongolian gerbils. Gastroenterology (2000) 1.58
Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia (1990) 1.58
The role of the autonomic innervation in the control of glucagon release during hypoglycaemia in the calf. J Physiol (1974) 1.58
Effect of neurotensin on gastric function in man. Lancet (1980) 1.55
Calcitonin gene-related peptide in cardiovascular tissues of the rat. Neuroscience (1985) 1.55
The increasing prevalence of acalculous cholecystitis in outpatients. Results of a 7-year study. Ann Surg (1990) 1.54
Identification of a small GTP-binding protein, Rab25, expressed in the gastrointestinal mucosa, kidney, and lung. J Biol Chem (1993) 1.52
Endocrine responses to insulin hypoglycaemia in the young calf. J Physiol (1975) 1.52
Release of glucagon, induced by stress. Q J Exp Physiol Cogn Med Sci (1973) 1.51
Erythromycin for reflex ileus in Ogilvie's syndrome. Lancet (1991) 1.50
Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut (2005) 1.49
Cloning, characterization, and DNA sequence of a human cDNA encoding neuropeptide tyrosine. Proc Natl Acad Sci U S A (1984) 1.49
Hypothermia and acidosis worsen coagulopathy in the patient requiring massive transfusion. Am J Surg (1990) 1.47
Specific localisation of neurotensin to the N cell in human intestine by radioimmunoassay and immunocytochemistry. Nature (1977) 1.47
Helicobacter pylori--more light, less heat. Am J Gastroenterol (1998) 1.46
Gut regulatory peptides and intestinal permeability in acute infantile gastroenteritis. Arch Dis Child (1992) 1.46
Lithium intoxication. BMJ (1991) 1.45
Long-term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases. Gastroenterology (1985) 1.44
Pancreatic cholera due to production of gastric inhibitory polypeptide. Lancet (1972) 1.44
Endothelin 1, an endothelium-derived peptide, is expressed in neurons of the human spinal cord and dorsal root ganglia. Proc Natl Acad Sci U S A (1989) 1.44
New autonomic and sensory neuropathy with loss of adrenergic sympathetic function and sensory neuropeptides. Lancet (1991) 1.43
Enrichment of rab11, a small GTP-binding protein, in gastric parietal cells. Am J Physiol (1994) 1.43
Postprandial plasma ghrelin is suppressed proportional to meal calorie content in normal-weight but not obese subjects. J Clin Endocrinol Metab (2004) 1.43
Current problems in the measurement of gastrin release. A reproducible measure of physiological gastrin release. Postgrad Med J (1976) 1.42